INTERNATIONAL PATENT: AZAFAROS B.V. FILES APPLICATION FOR "TREATMENT OF GM1 GANGLIOSIDOSIS"

GENEVA, Aug. 10 -- AZAFAROS B.V. (J.H. Oortweg 212333 CH Leiden) filed a patent application (PCT/EP2025/051297) for "TREATMENT OF GM1 GANGLIOSIDOSIS" on Jan 20, 2025. With publication no. WO/2025/162745, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LANDSKRONER, Kyle (c/o Azafaros AGDufourstrasse 254052 Basel), WHEREAT, Jeremy (Stem Cell Engineering GroupAustralian Institute for Bioengineering & NanotechnologyThe University of QueenslandCorner College and Cooper Rds (Bldg 75)Brisbane, Queensland 4072), PIETROGRANDE, Gio...